Fresenius Kabi, Formycon secure U.S. license date for proposed Stelara biosimilarThe proposed Stelara biosimilar is a human monoclonal antibody for treatment of immune-mediated disorders. Novartis spin-off of Sandoz generics drug unit to occur on or around Oct. 4Novartis said it is confident that the spin-off is in the best interests of shareholders. Adheris Health rebrands as MedAdvisor Solutions The rebranding is part of a global initiative to consolidate the MedAdvisor business units and B2B brands into one global B2B brand and enterprise structure. Blue Shield of California drops CVS Caremark, collaborates with Amazon Pharmacy, Mark Cuban Cost Plus Drug Company Blue Shield of California has selected five companies to collaborate with in a new model that is intended to save $500 million in annual drug costs. Glenmark obtains FDA nod for generic Protopic Protopic Ointment had a market value of approximately $15.4 million for the 12 month period ending June 2023, per IQVIA. Upsher-Smith debuts generic Pepcid Famotidine Oral Suspension had a market value of approximately $73 million for the 12 months ending June 2023, per IQVIA. Aldi to acquire Winn-Dixie and Harveys Supermarket The acquisition will add approximately 400 Winn-Dixie and Harveys Supermarket locations across Alabama, Florida, Georgia, Louisiana and Mississippi. Cardinal Health posts revenue growth in Q4, full year Cardinal Health’s fourth quarter revenue increased 13% to $53.5 billion, while fiscal year 2023 revenues rose 13% to $205 billion. Walgreens, VillageMD open Village Medical in Chicago Village Medical at Walgreens is a primary care practice located alongside a Walgreens pharmacy location. Kroger bringing additional resources to associates Kroger said it will offer more associates programs aimed at continuing education and financial literacy. First Previous 39 40 41 42 43 Next Last
